Cardiolynx

Cardiolynx Focuses on Novel Therapies for Cardiometabolic DiseasesCardiolynx focuses on novel therapies for cardiometabolic diseases, a broad therapeutic area with significant unmet medical needs and substantial growth potential. Building on known drug intervention targets, Cardiolynx optimizes and combines established therapies in novel and more effective ways. The cornerstone of the Cardiolynx approach is nitric oxide (NO), a versatile messenger in the cardiovascular system. By combining the effects of NO with other well-known molecules through fixed-dose combinations or novel hybrid molecules, Cardiolynx aims to develop a broader portfolio of highly effective and convenient therapies to improve patient care and quality of life.